June 15, 2020 Posted in Press ReleasesGAITHERSBURG, Md., June 15, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has entered into an agreement to sell Series A Convertible preferred stock, convertible into 4,388,852 shares of common stock, to an investment fund affiliated with RA Capital Management […]Read More
Daily Archives June 15, 2020
The Lao PDR has so far avoided a major health crisis but has not been immune from the global economic downturn as the COVID-19-induced economic recession has affected the country through multiple chan...Read More
The U.S. Food and Drug Administration Monday revoked emergency use authorization for a malaria drug that President Donald Trump hailed as a successful treatment for COVID-19.
The FDA said there is gro...
For the fourth time in its history, the Oscars are being postponed...Read More